These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 3024863)

  • 21. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
    Bauer WR; Neubauer S; Obitz G; Ertl G
    J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twice-daily low-dose captopril in diuretic-treated hypertensives.
    Murdoch DL; Gillen GJ; Morton JJ; Leckie B; Murray GD; Davies DL; McInnes GT
    J Hum Hypertens; 1989 Feb; 3(1):29-33. PubMed ID: 2657056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of captopril on the coronary circulation in a clinical and experimental study].
    Hăulică I; Topoliceanu F; Cosovanu A; Ungureanu G; Boişteanu D; Zaharia D
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(4):741-6. PubMed ID: 2700046
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin converting enzyme and memory: preclinical and clinical data.
    Sudilovsky A; Turnbull B; Croog SH; Crook T
    Int J Neurol; 1987-1988; 21-22():145-62. PubMed ID: 2856549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of converting-enzyme inhibition on cardiorenal hemodynamics in patients with chronic congestive heart failure.
    Kubo S; Nishioka A; Nishimura H; Kawamura K; Takatsu T
    J Cardiovasc Pharmacol; 1985; 7(4):753-9. PubMed ID: 2410718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Increased sensitivity of the cardiovascular system to captopril after microsphere embolization of the coronary vessels].
    Gorodetskaia EA; Allabergenova EA; Moleva EB; Medvedev OS
    Biull Eksp Biol Med; 1991 Aug; 112(8):122-4. PubMed ID: 1786365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of prolonged inhibition of angiotensin converting enzyme by captopril on some hemodynamic parameters of pulmonary circulation in patients with secondary pulmonary hypertension.
    Dubiel JP; Zmudka K; Brzostek T; Horzela T
    Acta Med Pol; 1989; 30(1-2):23-30. PubMed ID: 2488759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The increase in coronary flow induced by converting enzyme inhibitors is prostacyclin independent.
    Tio RA; van Wijngaarden J; Scholtens E; van Gilst WH; de Langen CD; Wesseling H
    Prog Clin Biol Res; 1989; 301():435-9. PubMed ID: 2552464
    [No Abstract]   [Full Text] [Related]  

  • 29. [The cardioprotective action of captopril during atrial electrostimulation].
    Cosovanu A; Ungureanu G; Roşca V; Hăulică I
    Rev Med Chir Soc Med Nat Iasi; 1989; 93(2):251-5. PubMed ID: 2682903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of angiotensin converting enzyme inhibition of coronary blood flow and hemodynamics in patients without coronary artery disease.
    Faxon DP; Creager MA; Halperin JL; Sussman HA; Gavras H; Ryan TJ
    Int J Cardiol; 1982; 2(2):251-62. PubMed ID: 6185446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute effects of captopril on the coronary circulation of patients with hypertension and angina.
    Daly P; Rouleau JL; Cousineau D; Burgess JH
    Am J Med; 1984 May; 76(5B):111-5. PubMed ID: 6328981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic response to converting enzyme inhibition at rest and exercise in humans.
    Fagard R; Lijnen P; Vanhees L; Amery A
    J Appl Physiol Respir Environ Exerc Physiol; 1982 Sep; 53(3):576-81. PubMed ID: 6290435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor.
    Ertl G; Kloner RA; Alexander RW; Braunwald E
    Circulation; 1982 Jan; 65(1):40-8. PubMed ID: 6273010
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of captopril (SQ14,225) on the systemic and coronary haemodynamics of the intact anaesthetized dog.
    Maxwell GM; Rencis V; Ness D
    Clin Exp Pharmacol Physiol; 1981 Jan; 8(1):17-23. PubMed ID: 7008989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Reduction of regurgitation in aortic insufficiency by inhibition of the renin-angiotensin converting enzyme].
    Reske SN; Kropp J; Heck I; Mattern H; Biersack HJ; Knopp R
    Nuklearmedizin; 1984 Oct; 23(5):241-5. PubMed ID: 6097878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cellular immunity in patients with psoriasis].
    Mutevelić-Arslanagić N
    Acta Med Iugosl; 1989; 43(1):13-20. PubMed ID: 2711859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary vascular remodeling and myocardial fibrosis in the rat with renovascular hypertension. Response to captopril.
    Jalil JE; Janicki JS; Pick R; Weber KT
    Am J Hypertens; 1991 Jan; 4(1 Pt 1):51-5. PubMed ID: 2006997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of preoperative renin-angiotensin system blockade on hypertension following coronary surgery.
    Colson P; Grolleau D; Chaptal PA; Ribstein J; Mimran A; Roquefeuil B
    Chest; 1988 Jun; 93(6):1156-8. PubMed ID: 3286140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemodynamics and sodium balance in conscious sodium-depleted rats.
    Salgado HC; Salgado MC; Krieger EM
    Braz J Med Biol Res; 1985; 18(1):47-54. PubMed ID: 4063547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Captopril-induced increase in coronary flow: an SH-dependent effect on arachidonic acid metabolism?
    van Gilst WH; van Wijngaarden J; Scholtens E; de Graeff PA; de Langen CD; Wesseling H
    J Cardiovasc Pharmacol; 1987; 9 Suppl 2():S31-6. PubMed ID: 2441198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.